miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression.

Li-Kun Hou, Yue Yu, Ye-Gong Xie, Jie Wang, Jie-Fei Mao, Bin Zhang, Xin Wang, Xu-Chen Cao
Author Information
  1. Li-Kun Hou: The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
  2. Yue Yu: The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
  3. Ye-Gong Xie: The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
  4. Jie Wang: The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
  5. Jie-Fei Mao: The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
  6. Bin Zhang: The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
  7. Xin Wang: The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
  8. Xu-Chen Cao: The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.

Abstract

MicroRNAs act as key regulators in carcinogenesis and progression in various cancers. In present study, we explored the role of miR-340 in the breast cancer progression. Our results showed that overexpression of miR-340 inhibits breast cancer cell proliferation and invasion, whereas depletion of miR-340 promotes breast cancer progression. Molecularly, ZEB1 was identified as a target gene of miR-340 and miR-340 suppressed the expression of ZEB1 by directly binding to the 3'-UTR of ZEB1. Furthermore, ZEB1 transcriptionally suppresses miR-340 expression. The negative feedback loop regulated TGF-β-mediated breast cancer progression. In conclusion, our data suggested that miR-340 acted as a tumor suppressor in breast cancer progression.

Keywords

References

  1. J Biomed Sci. 2015 Jan 23;22:9 [PMID: 25614041]
  2. Int J Cancer. 2014 Sep 15;135(6):1356-68 [PMID: 24615544]
  3. FEBS Lett. 2015 Jun 22;589(14):1577-87 [PMID: 25979173]
  4. Dis Markers. 2015;2015:327287 [PMID: 25918453]
  5. Biochem Biophys Res Commun. 2013 Aug 9;437(4):653-8 [PMID: 23872151]
  6. Cancer Res. 2008 Oct 1;68(19):7846-54 [PMID: 18829540]
  7. Tumour Biol. 2016 Jul;37(7):8993-9000 [PMID: 26758430]
  8. Surgery. 2014 Jul;156(1):97-108 [PMID: 24929761]
  9. PLoS One. 2015 May 01;10(5):e0125714 [PMID: 25933027]
  10. PLoS One. 2015 Apr 13;10(4):e0124340 [PMID: 25875827]
  11. Oncol Rep. 2016 Feb;35(2):709-16 [PMID: 26573744]
  12. Oncotarget. 2015 Oct 27;6(33):34423-36 [PMID: 26460733]
  13. Cell. 2003 Jun 13;113(6):673-6 [PMID: 12809598]
  14. Br J Cancer. 2015 Jan 6;112(1):167-70 [PMID: 25290086]
  15. Clin Med Insights Pathol. 2015 Jan 07;8:1-16 [PMID: 25624778]
  16. Br J Cancer. 2015 Jan 6;112(1):61-8 [PMID: 25474246]
  17. CA Cancer J Clin. 2015 Jan-Feb;65(1):30-54 [PMID: 25581023]
  18. Mol Cancer Ther. 2014 Apr;13(4):976-85 [PMID: 24448820]
  19. Int J Cancer. 2015 Feb 1;136(3):593-602 [PMID: 24917463]
  20. Cell Cycle. 2015 ;14 (4):481-7 [PMID: 25607528]
  21. J Oncol. 2015;2015:865816 [PMID: 25883654]
  22. Br J Cancer. 2014 Feb 4;110(3):724-32 [PMID: 24335925]
  23. Cell Death Dis. 2014 Oct 02;5:e1443 [PMID: 25275602]
  24. Oncogene. 2015 Jun;34(25):3240-50 [PMID: 25151966]
  25. Environ Health Perspect. 2015 May;123(5):399-411 [PMID: 25616258]
  26. Br J Cancer. 2014 Nov 25;111(11):2142-51 [PMID: 25268374]
  27. Oncotarget. 2015 Jun 10;6(16):14399-412 [PMID: 25973542]
  28. Oncotarget. 2015 Jul 10;6(19):17404-16 [PMID: 25965817]
  29. Oncotarget. 2016 Apr 12;7(15):19531-47 [PMID: 26799668]
  30. Gene. 2015 Apr 10;560(1):77-82 [PMID: 25644077]
  31. Mol Cancer. 2014 Apr 23;13:86 [PMID: 24755295]
  32. Breast Cancer (Dove Med Press). 2015 Jan 19;7:9-19 [PMID: 25632238]
  33. BMC Pulm Med. 2014 Oct 31;14 :168 [PMID: 25358403]
  34. Clin Transl Med. 2015 Feb 26;4:6 [PMID: 25852822]
  35. Oncotarget. 2015 Apr 20;6(11):9257-70 [PMID: 25831237]
  36. Oncotarget. 2015 Apr 20;6(11):8434-53 [PMID: 25726529]
  37. Cancer. 2011 Jul 1;117(13):2842-52 [PMID: 21692045]
  38. J Surg Oncol. 2015 Jan;111(1):81-90 [PMID: 25091830]
  39. Biochem Biophys Res Commun. 2015 May 8;460(3):670-7 [PMID: 25817794]
  40. PLoS One. 2013 Jul 02;8(7):e67686 [PMID: 23844063]

MeSH Term

Apoptosis
Biomarkers, Tumor
Breast Neoplasms
Cell Adhesion
Cell Movement
Cell Proliferation
Disease Progression
Epithelial-Mesenchymal Transition
Feedback, Physiological
Female
Gene Expression Regulation, Neoplastic
Humans
MicroRNAs
Transforming Growth Factor beta
Tumor Cells, Cultured
Zinc Finger E-box-Binding Homeobox 1

Chemicals

Biomarkers, Tumor
MIRN340 microRNA, human
MicroRNAs
Transforming Growth Factor beta
ZEB1 protein, human
Zinc Finger E-box-Binding Homeobox 1

Word Cloud

Created with Highcharts 10.0.0miR-340breastcancerprogressionZEB1expressionnegativefeedbackloopMicroRNAsactkeyregulatorscarcinogenesisvariouscancerspresentstudyexploredroleresultsshowedoverexpressioninhibitscellproliferationinvasionwhereasdepletionpromotesMolecularlyidentifiedtargetgenesuppresseddirectlybinding3'-UTRFurthermoretranscriptionallysuppressesregulatedTGF-β-mediatedconclusiondatasuggestedactedtumorsuppressorregulatesTGF-β-mediatedEMTTGF-β

Similar Articles

Cited By